AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
PATTERNS OF DRUG-USE IN RHEUMATOID-ARTHRITIS
Authors: MACLEAN CH LEAKE B PAULUS HE BROOK RH SHEKELLE PG
Citation: Ch. Maclean et al., PATTERNS OF DRUG-USE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 266-266
LONGITUDINAL COMPARISON OF IMPROVEMENT IN PATIENT SELF-REPORT AND PHYSICIAN PERFORMED TENDER AND SWOLLEN JOINT COUNTS OVER 6-12 MONTHS IN EARLY RA
Authors: WONG AL HARKER J WONG WK BUTPITT K RAMOS B PARK G STERZ M PAULUS HE
Citation: Al. Wong et al., LONGITUDINAL COMPARISON OF IMPROVEMENT IN PATIENT SELF-REPORT AND PHYSICIAN PERFORMED TENDER AND SWOLLEN JOINT COUNTS OVER 6-12 MONTHS IN EARLY RA, Arthritis and rheumatism, 41(9), 1998, pp. 1137-1137
COMPARISON OF PATIENT AND PHYSICIAN RANKINGS OF THE IMPORTANCE OF DISEASE AND LIFE FACTORS IN EARLY RA (LESS-THAN-OR-EQUAL-TO-1 YEAR)
Authors: PARK G BULPITT KJ STERZ MG WONG WK RAMOS B CLEMENTS PJ PAULUS HE
Citation: G. Park et al., COMPARISON OF PATIENT AND PHYSICIAN RANKINGS OF THE IMPORTANCE OF DISEASE AND LIFE FACTORS IN EARLY RA (LESS-THAN-OR-EQUAL-TO-1 YEAR), Arthritis and rheumatism, 41(9), 1998, pp. 1175-1175
QUALITY OF CARE FOR COMORBID DISEASE AND HEALTH-CARE MAINTENANCE IN RHEUMATOID-ARTHRITIS
Authors: MACLEAN CH LEAKE B PAULUS HE BROOK RH SHEKELLE PG
Citation: Ch. Maclean et al., QUALITY OF CARE FOR COMORBID DISEASE AND HEALTH-CARE MAINTENANCE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1296-1296
PREDICTORS OF 1-YEAR AND 2-YEAR ACR RESPONSE IN EARLY RA PATIENTS FOLLOWED FROM WITHIN 1-YEAR OF SYMPTOM ONSET
Authors: BULPITT KJ CLEMENTS PJ WONG WK BERKANOVIC E STERZ MG WONG AL OSTER P RAMOS B LAW J PARK G NEPOM G PETER JB PAULUS HE
Citation: Kj. Bulpitt et al., PREDICTORS OF 1-YEAR AND 2-YEAR ACR RESPONSE IN EARLY RA PATIENTS FOLLOWED FROM WITHIN 1-YEAR OF SYMPTOM ONSET, Arthritis and rheumatism, 40(9), 1997, pp. 389-389
PATIENT SELF-REPORT TENDER AND SWOLLEN JOINT COUNTS IN EARLY RHEUMATOID-ARTHRITIS
Authors: WONG AL STERZ M WONG WK HE WZ PAULUS HE
Citation: Al. Wong et al., PATIENT SELF-REPORT TENDER AND SWOLLEN JOINT COUNTS IN EARLY RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 40(9), 1997, pp. 494-494
EROSION PROGRESSION DURING EARLY SEROPOSITIVE RA
Authors: BULPITT KJ SHARP JT GOLD R STERZ MG CLEMENTS PJ WONG WK OSTER P WONG AL RAMOS B LAW J PARK G NEPOM G PETER JB PAULUS HE
Citation: Kj. Bulpitt et al., EROSION PROGRESSION DURING EARLY SEROPOSITIVE RA, Arthritis and rheumatism, 40(9), 1997, pp. 1543-1543
GENDER DIFFERENCES IN THE PSYCHOSOCIAL IMPACT OF SEVERE RA WITHIN THEFIRST YEAR OF DISEASE
Authors: OSTER P BERKANOVIC E BULPITT KJ LAW J WONG WK CLEMENTS PJ STERZ MG PAULUS HE
Citation: P. Oster et al., GENDER DIFFERENCES IN THE PSYCHOSOCIAL IMPACT OF SEVERE RA WITHIN THEFIRST YEAR OF DISEASE, Arthritis and rheumatism, 40(9), 1997, pp. 1686-1686
MONITORING RADIOGRAPHIC CHANGES IN EARLY RHEUMATOID-ARTHRITIS
Authors: PAULUS HE VANDERHEIJDE DMFM BULPITT KJ GOLD RH
Citation: He. Paulus et al., MONITORING RADIOGRAPHIC CHANGES IN EARLY RHEUMATOID-ARTHRITIS, Journal of rheumatology, 23(5), 1996, pp. 801-805
HISTORY OF COMBINATION THERAPY OF RHEUMATOID-ARTHRITIS
Authors: PAULUS HE
Citation: He. Paulus, HISTORY OF COMBINATION THERAPY OF RHEUMATOID-ARTHRITIS, Journal of rheumatology, 23, 1996, pp. 38-42
INAPPROPRIATE DRUG-USE IN RHEUMATOID-ARTHRITIS
Authors: MACLEAN CH KNIGHT KK SHEKELLE PG PAULUS HE BROOK RH
Citation: Ch. Maclean et al., INAPPROPRIATE DRUG-USE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(9), 1996, pp. 1083-1083
COSTS ATTRIBUTABLE TO ARTHRITIS
Authors: MACLEAN CH KNIGHT KK SHEKELLE PG PAULUS HE BROOK RH
Citation: Ch. Maclean et al., COSTS ATTRIBUTABLE TO ARTHRITIS, Arthritis and rheumatism, 39(6), 1996, pp. 4-4
DRUG-USE IN RHEUMATOID-ARTHRITIS
Authors: MACLEAN CH KNIGHT KK SHEKELLE PG PAULUS HE BROOK RH
Citation: Ch. Maclean et al., DRUG-USE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(6), 1996, pp. 5-5
EARLY UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE
Authors: ALARCON GS WILLKENS RF WARD JR CLEGG DO MORGAN JG MA KN SINGER JZ STEEN VD PAULUS HE LUGGEN ME POLISSON RP ZIMINSKI CM YARBORO C WILLIAMS HJ
Citation: Gs. Alarcon et al., EARLY UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE, Arthritis and rheumatism, 39(3), 1996, pp. 403-414
COMBINATION THERAPY
Authors: BORIGINI MJ PAULUS HE
Citation: Mj. Borigini et He. Paulus, COMBINATION THERAPY, Bailliere's clinical rheumatology, 9(4), 1995, pp. 689-710
OUTCOME MEASURES
Authors: PAULUS HE BULPITT KJ
Citation: He. Paulus et Kj. Bulpitt, OUTCOME MEASURES, Rheumatic diseases clinics of North America, 21(3), 1995, pp. 605-618
CLINICAL-TRIAL DESIGN FOR EVALUATING COMBINATION THERAPIES
Authors: PAULUS HE
Citation: He. Paulus, CLINICAL-TRIAL DESIGN FOR EVALUATING COMBINATION THERAPIES, British journal of rheumatology, 34, 1995, pp. 92-95
X-RAY EROSIONS AND DR4 SUSCEPTIBILITY ALLELES IN EARLY ACTIVE RHEUMATOID-ARTHRITIS (LESS-THAN-OR-EQUAL-TO-12 MONTHS SYMPTOMS)
Authors: BULPITT KJ NEPOM G SHARP JT GOLD R CLEMENTS PJ WONG WK STERZ MG LEE M PAULUS HE
Citation: Kj. Bulpitt et al., X-RAY EROSIONS AND DR4 SUSCEPTIBILITY ALLELES IN EARLY ACTIVE RHEUMATOID-ARTHRITIS (LESS-THAN-OR-EQUAL-TO-12 MONTHS SYMPTOMS), Arthritis and rheumatism, 38(9), 1995, pp. 1065-1065
RA ASSOCIATED COSTS WITHIN THE FIRST YEAR OF DISEASE IN EARLY ACTIVE RA (LESS-THAN-OR-EQUAL-TO-12 MONTHS SYMPTOM DURATION)
Authors: NEWHALLPERRY K BULPITT KJ STERZ MG CLEMENTS PJ BERKANOVIC E WONG WK LEE M PAULUS HE
Citation: K. Newhallperry et al., RA ASSOCIATED COSTS WITHIN THE FIRST YEAR OF DISEASE IN EARLY ACTIVE RA (LESS-THAN-OR-EQUAL-TO-12 MONTHS SYMPTOM DURATION), Arthritis and rheumatism, 38(9), 1995, pp. 1384-1384
GUIDELINES FOR CLINICAL-TRIALS IN SYSTEMIC-SCLEROSIS (SCLERODERMA) .1. DISEASE-MODIFYING INTERVENTIONS
Authors: WHITE B BAUER EA GOLDSMITH LA HOCHBERG MC KATZ LM KORN JH LACHENBRUCH PA LEROY EC MITRANE MP PAULUS HE POSTLETHWAITE AE STEEN VD
Citation: B. White et al., GUIDELINES FOR CLINICAL-TRIALS IN SYSTEMIC-SCLEROSIS (SCLERODERMA) .1. DISEASE-MODIFYING INTERVENTIONS, Arthritis and rheumatism, 38(3), 1995, pp. 351-360
MINOCYCLINE AND RHEUMATOID-ARTHRITIS REVISITED - RESPONSE
Authors: PAULUS HE
Citation: He. Paulus, MINOCYCLINE AND RHEUMATOID-ARTHRITIS REVISITED - RESPONSE, Annals of internal medicine, 123(5), 1995, pp. 393-393
MINOCYCLINE TREATMENT OF RHEUMATOID-ARTHRITIS
Authors: PAULUS HE
Citation: He. Paulus, MINOCYCLINE TREATMENT OF RHEUMATOID-ARTHRITIS, Annals of internal medicine, 122(2), 1995, pp. 147-148
DC-ART CLASSIFICATION - REVIEW OF RELEVANT CLINICAL-STUDIES
Authors: PAULUS HE BULPITT KJ
Citation: He. Paulus et Kj. Bulpitt, DC-ART CLASSIFICATION - REVIEW OF RELEVANT CLINICAL-STUDIES, Journal of rheumatology, 21, 1994, pp. 8-20
OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS - PROCEEDINGS OF A SATELLITESYMPOSIUM, 57TH AMERICAN-COLLEGE-OF-RHEUMATOLOGY, NATIONAL SYMPOSIUM,SAN-ANTONIO, TEXAS, USA, NOVEMBER 11, 1993 - INTRODUCTION
Authors: PAULUS HE
Citation: He. Paulus, OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS - PROCEEDINGS OF A SATELLITESYMPOSIUM, 57TH AMERICAN-COLLEGE-OF-RHEUMATOLOGY, NATIONAL SYMPOSIUM,SAN-ANTONIO, TEXAS, USA, NOVEMBER 11, 1993 - INTRODUCTION, Journal of rheumatology, 21(10), 1994, pp. 1-1
FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - THERAFECTIN - ROLE OF ARTHRITIS ADVISORY-COMMITTEE IN FDA REVIEW PROCESS - PERSONNEL CHANGES - ISSUES OF OVER-THE-COUNTER SWITCHING
Authors: FURST DE PAULUS HE
Citation: De. Furst et He. Paulus, FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - THERAFECTIN - ROLE OF ARTHRITIS ADVISORY-COMMITTEE IN FDA REVIEW PROCESS - PERSONNEL CHANGES - ISSUES OF OVER-THE-COUNTER SWITCHING, Arthritis and rheumatism, 37(9), 1994, pp. 1408-1409
Risultati: 1-25 | 26-36